Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News Kymera Therapeutics advances Phase 2 trials of KT-474 in partnership with Sanofi Kymera Therapeutics, Inc. (NASDAQ: KYMR), a leader in the biopharmaceutical sector focusing on targeted protein degradation (TPD), has… byPallavi MadhirajuJuly 9, 2024